NCT01846702View on ClinicalTrials.gov

A Study of LY3084077 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Given as a SC injection.

DRUG

LY3084077

Given as a SC injection.

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01846702 - A Study of LY3084077 in Healthy Participants | Biotech Hunter | Biotech Hunter